Everence Capital Management’s Celgene Corp CELG Stock Holding History

Everence Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,519	Closed	-$1.64M	–	715
2019 Q3	$1.64M	Hold	16,519	–	–	0.27%	86
2019 Q2	$1.53M	Sell	16,519 -3,030	-15%	-$288K	0.25%	89
2019 Q1	$1.84M	Buy	19,549 +446	+2%	+$39K	0.32%	71
2018 Q4	$1.22M	Hold	19,103	–	–	0.28%	92
2018 Q3	$1.71M	Hold	19,103	–	–	0.34%	71
2018 Q2	$1.52M	Hold	19,103	–	–	0.32%	75
2018 Q1	$1.7M	Hold	19,103	–	–	0.38%	65
2017 Q4	$1.99M	Buy	19,103 +2,373	+14%	+$268K	0.44%	55
2017 Q3	$2.44M	Buy	16,730 +1,700	+11%	+$232K	0.56%	42
2017 Q2	$1.95M	Hold	15,030	–	–	0.48%	48
2017 Q1	$1.87M	Hold	15,030	–	–	0.49%	49
2016 Q4	$1.74M	Sell	15,030 -1,728	-10%	-$192K	0.5%	51
2016 Q3	$1.75M	Hold	16,758	–	–	0.52%	49
2016 Q2	$1.65M	Hold	16,758	–	–	0.51%	50
2016 Q1	$1.68M	Hold	16,758	–	–	0.52%	51
2015 Q4	$2.01M	Hold	16,758	–	–	0.65%	41
2015 Q3	$1.81M	Hold	16,758	–	–	0.63%	44
2015 Q2	$1.94M	Hold	16,758	–	–	0.63%	44
2015 Q1	$2.04M	Hold	16,758	–	–	0.68%	37
2014 Q4	$1.88M	Hold	16,758	–	–	0.64%	40
2014 Q3	$1.59M	Buy	16,758 +7,459	+80%	+$673K	0.58%	47
2014 Q2	$799K	Sell	9,299 -9,299	-50%	-$707K	0.3%	113
2014 Q1	$1.3M	Hold	18,598	–	–	0.51%	53
2013 Q4	$1.57M	Sell	18,598 -1,760	-9%	-$139K	0.63%	42
2013 Q3	$1.57M	Hold	20,358	–	–	0.67%	38
2013 Q2	$1.19M	Buy	+20,358	New	+$1.23M	0.54%	53

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Everence Capital Management's CELG Position: Q4 2019 in Review

Everence Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,519 shares — an estimated $1.64M sold.

Everence Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.44M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Everence Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Everence Capital Management sold 16,519 Celgene Corp shares in Q4 2019, an estimated $1.64M.
Everence Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
Everence Capital Management's Celgene Corp position peaked at $2.44M in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Everence Capital Management's 13F filing for Q4 2019, filed 28 Jan 2020.